Redmile Group LLC 13D/13G Filings for TCR2 Therapeutics Inc. (TCRR)

Redmile Group LLC 13D and 13G filings for TCR2 Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
5:07 pm
Sale		 2021-12-31 13G TCR2 Therapeutics Inc.
TCRR		 Redmile Group LLC 1,346,058
3.500%		 -1,486,830decrease
(-52.48%)		 Filing
2021-02-16
4:09 pm
Purchase		 2020-12-31 13G TCR2 Therapeutics Inc.
TCRR		 Redmile Group LLC 2,832,888
8.500%		 1,033,700increase
(+57.45%)		 Filing